Arteris, Inc. (NASDAQ:AIP) Shares Sold by Eventide Asset Management LLC

Eventide Asset Management LLC lowered its stake in Arteris, Inc. (NASDAQ:AIP) by 9.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 317,625 shares of the company’s stock after selling 31,366 shares during the period. Eventide Asset Management LLC’s holdings in Arteris were worth $2,452,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. US Bancorp DE purchased a new position in Arteris in the 3rd quarter valued at $34,000. The Manufacturers Life Insurance Company acquired a new stake in shares of Arteris in the 2nd quarter worth $86,000. Algert Global LLC purchased a new stake in shares of Arteris in the second quarter valued at about $115,000. MetLife Investment Management LLC increased its stake in shares of Arteris by 129.1% during the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after acquiring an additional 9,551 shares during the period. Finally, Dynamic Technology Lab Private Ltd purchased a new position in Arteris during the third quarter worth about $226,000. Hedge funds and other institutional investors own 64.36% of the company’s stock.

Arteris Stock Performance

NASDAQ:AIP opened at $8.69 on Friday. The firm’s fifty day simple moving average is $7.62 and its 200-day simple moving average is $7.75. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 0.30. The stock has a market cap of $349.16 million, a PE ratio of -9.05 and a beta of 1.13. Arteris, Inc. has a fifty-two week low of $4.83 and a fifty-two week high of $9.54.

Insider Buying and Selling

In other news, CFO Nicholas B. Hawkins sold 19,299 shares of the firm’s stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $8.14, for a total value of $157,093.86. Following the completion of the transaction, the chief financial officer now owns 192,414 shares in the company, valued at $1,566,249.96. This trade represents a 9.12 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Laurent R. Moll sold 37,561 shares of Arteris stock in a transaction on Wednesday, September 4th. The stock was sold at an average price of $7.49, for a total value of $281,331.89. Following the transaction, the chief operating officer now directly owns 544,468 shares of the company’s stock, valued at $4,078,065.32. This trade represents a 6.45 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 143,409 shares of company stock valued at $1,059,138. Corporate insiders own 33.70% of the company’s stock.

Analyst Ratings Changes

Separately, Rosenblatt Securities reiterated a “buy” rating and set a $15.00 target price on shares of Arteris in a research report on Wednesday, November 6th.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.